- Home
- APRE vs FRSX Comparison
APRE vs FRSX Comparison
Compare APRE & FRSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APRE
- FRSX
- Stock Information
- Founded
- APRE 2006
- FRSX N/A
- Country
- APRE United States
- FRSX Israel
- Employees
- APRE N/A
- FRSX N/A
- Industry
- APRE Biotechnology: Biological Products (No Diagnostic Substances)
- FRSX Computer Software: Prepackaged Software
- Sector
- APRE Health Care
- FRSX Technology
- Exchange
- APRE Nasdaq
- FRSX Nasdaq
- Market Cap
- APRE 10.0M
- FRSX 9.8M
- IPO Year
- APRE 2019
- FRSX 2017
- Fundamental
- Price
- APRE $1.71
- FRSX $0.51
- Analyst Decision
- APRE Strong Buy
- FRSX
- Analyst Count
- APRE 2
- FRSX 0
- Target Price
- APRE $15.50
- FRSX N/A
- AVG Volume (30 Days)
- APRE 50.9K
- FRSX 440.7K
- Earning Date
- APRE 08-11-2025
- FRSX 08-08-2025
- Dividend Yield
- APRE N/A
- FRSX N/A
- EPS Growth
- APRE N/A
- FRSX N/A
- EPS
- APRE N/A
- FRSX N/A
- Revenue
- APRE $1,284,475.00
- FRSX $436,000.00
- Revenue This Year
- APRE N/A
- FRSX N/A
- Revenue Next Year
- APRE N/A
- FRSX N/A
- P/E Ratio
- APRE N/A
- FRSX N/A
- Revenue Growth
- APRE 33.27
- FRSX N/A
- 52 Week Low
- APRE $1.41
- FRSX $0.45
- 52 Week High
- APRE $5.01
- FRSX $2.63
- Technical
- Relative Strength Index (RSI)
- APRE 52.34
- FRSX 40.79
- Support Level
- APRE $1.48
- FRSX $0.45
- Resistance Level
- APRE $1.91
- FRSX $0.52
- Average True Range (ATR)
- APRE 0.16
- FRSX 0.04
- MACD
- APRE -0.00
- FRSX -0.00
- Stochastic Oscillator
- APRE 63.14
- FRSX 25.15
About APRE Aprea Therapeutics Inc. Common stock
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.
About FRSX Foresight Autonomous Holdings Ltd.
Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.